(Q35747962)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15089783%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

review article

1 reference

title

Prevention of Type 2 diabetes mellitus. A review of the evidence and its application in a UK setting (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15089783%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15089783%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

author name string

M J Davies

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15089783%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

J R Tringham

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15089783%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

J Troughton

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15089783%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

publication date

1 May 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15089783%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15089783%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15089783%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

page(s)

403-414

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15089783%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15089783%20AND%20SRC:MED&resulttype=core&format=json

Diabetes--a common, growing, serious, costly, and potentially preventable public health problem.

27 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01176.X

Globalization, coca-colonization and the chronic disease epidemic: can the Doomsday scenario be averted?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01176.X

Weight gain as a risk factor for clinical diabetes mellitus in women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01176.X

Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01176.X

Obesity prevention: the case for action

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01176.X

Physical inactivity, sedentary lifestyle and obesity in the European Union

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01176.X

Prospective study of risk factors for development of non-insulin dependent diabetes in middle aged British men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01176.X

The association between cardiorespiratory fitness and impaired fasting glucose and type 2 diabetes mellitus in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01176.X

Fruit and vegetable intake and population glycosylated haemoglobin levels: the EPIC-Norfolk Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01176.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01176.X

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01176.X

Glucose tolerance and mortality, including a substudy of tolbutamide treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01176.X

Impaired glucose tolerance and fasting hyperglycaemia have different characteristics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01176.X

Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01176.X

PPAR gamma and the treatment of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01176.X

TRIPOD (TRoglitazone In the Prevention Of Diabetes): a randomized, placebo-controlled trial of troglitazone in women with prior gestational diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01176.X

Ramipril and the development of diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01176.X

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01176.X

Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01176.X

C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01176.X

Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01176.X

Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01176.X

Comparison of the fasting and the 2-h glucose criteria for diabetes in different Asian cohorts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01176.X

Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01176.X

Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01176.X

Impaired glucose tolerance: qualitative and quantitative study of general practitioners' knowledge and perceptions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01176.X

Preventing weight gain in adults: a pound of prevention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01176.X

Margarine intake and risk of nonfatal acute myocardial infarction in Italian women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01176.X

10.1111/J.1464-5491.2004.01176.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15089783%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference